| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mortality | 14 | 2024 | 260 | 2.740 |
Why?
|
| Alveolar Bone Loss | 3 | 2025 | 6 | 2.480 |
Why?
|
| Homicide | 5 | 2018 | 34 | 2.310 |
Why?
|
| Health Status Disparities | 11 | 2019 | 276 | 2.290 |
Why?
|
| Infant Mortality | 8 | 2024 | 184 | 2.180 |
Why?
|
| Dental Implants, Single-Tooth | 3 | 2021 | 3 | 1.790 |
Why?
|
| Guided Tissue Regeneration, Periodontal | 2 | 2023 | 2 | 1.600 |
Why?
|
| Dental Implants | 3 | 2021 | 7 | 1.540 |
Why?
|
| Cause of Death | 11 | 2024 | 509 | 1.450 |
Why?
|
| Esthetics, Dental | 4 | 2021 | 18 | 1.400 |
Why?
|
| Healthcare Disparities | 4 | 2020 | 506 | 1.310 |
Why?
|
| United States | 53 | 2026 | 11820 | 1.300 |
Why?
|
| Mitral Valve Prolapse | 5 | 2022 | 35 | 1.250 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 905 | 1.190 |
Why?
|
| Public Health | 9 | 2024 | 271 | 1.150 |
Why?
|
| Medicare | 9 | 2016 | 439 | 1.140 |
Why?
|
| Mammography | 8 | 2016 | 129 | 1.070 |
Why?
|
| Alcohol-Related Disorders | 3 | 2024 | 35 | 1.050 |
Why?
|
| Firearms | 4 | 2023 | 58 | 1.030 |
Why?
|
| Breast Neoplasms | 10 | 2018 | 2646 | 1.020 |
Why?
|
| Connective Tissue | 3 | 2021 | 26 | 1.010 |
Why?
|
| Patient Education as Topic | 6 | 2021 | 456 | 0.970 |
Why?
|
| Humans | 111 | 2026 | 130574 | 0.930 |
Why?
|
| Dental Implantation, Endosseous | 3 | 2021 | 5 | 0.930 |
Why?
|
| Colorectal Neoplasms | 3 | 2022 | 631 | 0.920 |
Why?
|
| Peri-Implantitis | 1 | 2025 | 1 | 0.910 |
Why?
|
| Analgesics, Opioid | 3 | 2023 | 470 | 0.900 |
Why?
|
| Multimedia | 2 | 2015 | 11 | 0.870 |
Why?
|
| Health Education | 4 | 2019 | 227 | 0.820 |
Why?
|
| Gingiva | 2 | 2021 | 11 | 0.810 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 1535 | 0.790 |
Why?
|
| Patient Care Planning | 3 | 2023 | 123 | 0.790 |
Why?
|
| Adult | 47 | 2024 | 31202 | 0.780 |
Why?
|
| Body Weight | 2 | 2018 | 988 | 0.780 |
Why?
|
| Law Enforcement | 3 | 2015 | 18 | 0.770 |
Why?
|
| Hypnosis | 1 | 2022 | 11 | 0.760 |
Why?
|
| Mitral Valve Insufficiency | 6 | 2023 | 185 | 0.760 |
Why?
|
| Meditation | 1 | 2022 | 19 | 0.750 |
Why?
|
| Aged | 43 | 2024 | 20925 | 0.740 |
Why?
|
| Aged, 80 and over | 20 | 2018 | 6773 | 0.730 |
Why?
|
| Female | 66 | 2024 | 70509 | 0.710 |
Why?
|
| Preventive Health Services | 2 | 2015 | 59 | 0.700 |
Why?
|
| Middle Aged | 42 | 2024 | 28448 | 0.690 |
Why?
|
| Male | 59 | 2024 | 64557 | 0.650 |
Why?
|
| Sex Factors | 10 | 2023 | 1336 | 0.650 |
Why?
|
| Gingival Recession | 1 | 2020 | 2 | 0.640 |
Why?
|
| Geographic Mapping | 1 | 2020 | 15 | 0.630 |
Why?
|
| Time Factors | 9 | 2020 | 6223 | 0.630 |
Why?
|
| Asphyxia | 1 | 2019 | 14 | 0.620 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2018 | 78 | 0.620 |
Why?
|
| Immediate Dental Implant Loading | 2 | 2018 | 2 | 0.610 |
Why?
|
| Sudden Infant Death | 1 | 2019 | 37 | 0.610 |
Why?
|
| Cryptococcosis | 1 | 2019 | 40 | 0.610 |
Why?
|
| Social Justice | 2 | 2017 | 65 | 0.580 |
Why?
|
| Depression | 3 | 2018 | 1318 | 0.570 |
Why?
|
| Altitude | 1 | 2018 | 22 | 0.570 |
Why?
|
| Mitral Valve | 4 | 2023 | 251 | 0.560 |
Why?
|
| Leadership | 1 | 2021 | 246 | 0.560 |
Why?
|
| Hospitalization | 6 | 2021 | 1932 | 0.550 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 78 | 0.550 |
Why?
|
| Medicaid | 3 | 2012 | 251 | 0.550 |
Why?
|
| Infant Death | 1 | 2017 | 2 | 0.540 |
Why?
|
| Culture | 1 | 2018 | 67 | 0.540 |
Why?
|
| Smoking | 2 | 2023 | 926 | 0.530 |
Why?
|
| Atrial Function | 1 | 2017 | 16 | 0.530 |
Why?
|
| Population Surveillance | 6 | 2019 | 395 | 0.530 |
Why?
|
| Urban Health | 1 | 2017 | 84 | 0.530 |
Why?
|
| Mitral Valve Stenosis | 1 | 2017 | 34 | 0.520 |
Why?
|
| Rheumatic Heart Disease | 1 | 2017 | 38 | 0.510 |
Why?
|
| Pain Management | 1 | 2019 | 197 | 0.510 |
Why?
|
| Adolescent | 25 | 2024 | 20774 | 0.510 |
Why?
|
| Ventricular Function | 1 | 2017 | 86 | 0.500 |
Why?
|
| Primary Health Care | 4 | 2022 | 783 | 0.490 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 295 | 0.490 |
Why?
|
| Young Adult | 14 | 2024 | 9991 | 0.490 |
Why?
|
| Palate | 3 | 2021 | 19 | 0.480 |
Why?
|
| Cultural Competency | 1 | 2016 | 50 | 0.470 |
Why?
|
| Mass Screening | 5 | 2009 | 806 | 0.460 |
Why?
|
| Pediatric Obesity | 3 | 2018 | 413 | 0.460 |
Why?
|
| Total Quality Management | 1 | 2015 | 22 | 0.460 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2018 | 252 | 0.450 |
Why?
|
| HIV Infections | 4 | 2019 | 2012 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 364 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 375 | 0.440 |
Why?
|
| Epidemiology | 1 | 2014 | 8 | 0.440 |
Why?
|
| Socioeconomic Factors | 9 | 2019 | 891 | 0.440 |
Why?
|
| Poverty | 2 | 2009 | 454 | 0.440 |
Why?
|
| Tennessee | 9 | 2013 | 34 | 0.430 |
Why?
|
| Early Detection of Cancer | 4 | 2022 | 418 | 0.420 |
Why?
|
| Disease | 2 | 2014 | 124 | 0.420 |
Why?
|
| Parenting | 1 | 2018 | 351 | 0.410 |
Why?
|
| Mothers | 1 | 2017 | 369 | 0.400 |
Why?
|
| Medically Uninsured | 2 | 2012 | 77 | 0.400 |
Why?
|
| Computer-Assisted Instruction | 1 | 2014 | 58 | 0.400 |
Why?
|
| Infant | 15 | 2024 | 13306 | 0.400 |
Why?
|
| Seat Belts | 3 | 2013 | 24 | 0.400 |
Why?
|
| Hemodynamics | 1 | 2017 | 809 | 0.390 |
Why?
|
| Health Services Accessibility | 5 | 2016 | 696 | 0.390 |
Why?
|
| United States Public Health Service | 1 | 2012 | 5 | 0.390 |
Why?
|
| Religion | 4 | 2009 | 45 | 0.380 |
Why?
|
| User-Computer Interface | 1 | 2014 | 158 | 0.380 |
Why?
|
| Human Experimentation | 1 | 2012 | 33 | 0.380 |
Why?
|
| Clonazepam | 1 | 2012 | 5 | 0.370 |
Why?
|
| Social Determinants of Health | 1 | 2014 | 160 | 0.370 |
Why?
|
| GABA Agonists | 1 | 2012 | 15 | 0.370 |
Why?
|
| Clinical Competence | 2 | 2017 | 1052 | 0.370 |
Why?
|
| Ginkgo biloba | 1 | 2012 | 11 | 0.370 |
Why?
|
| Tinnitus | 1 | 2012 | 23 | 0.360 |
Why?
|
| Uncompensated Care | 1 | 2012 | 11 | 0.360 |
Why?
|
| Phytotherapy | 1 | 2012 | 46 | 0.360 |
Why?
|
| Diabetes Mellitus | 4 | 2016 | 895 | 0.360 |
Why?
|
| Eligibility Determination | 1 | 2012 | 36 | 0.360 |
Why?
|
| Plant Extracts | 1 | 2012 | 136 | 0.330 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 703 | 0.330 |
Why?
|
| Regression Analysis | 5 | 2016 | 766 | 0.320 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 1124 | 0.320 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2010 | 257 | 0.310 |
Why?
|
| Cardiac Catheterization | 1 | 2014 | 634 | 0.300 |
Why?
|
| Collagen | 2 | 2021 | 284 | 0.300 |
Why?
|
| Child, Preschool | 12 | 2021 | 14987 | 0.290 |
Why?
|
| Accidents, Traffic | 2 | 2006 | 105 | 0.290 |
Why?
|
| Ambulatory Care | 1 | 2012 | 405 | 0.280 |
Why?
|
| Risk Factors | 13 | 2022 | 10993 | 0.280 |
Why?
|
| New York City | 2 | 2018 | 62 | 0.280 |
Why?
|
| Nursing Assessment | 1 | 2007 | 20 | 0.270 |
Why?
|
| Age Distribution | 4 | 2013 | 426 | 0.260 |
Why?
|
| Child | 16 | 2024 | 26145 | 0.260 |
Why?
|
| Emergency Service, Hospital | 2 | 2013 | 1206 | 0.260 |
Why?
|
| Alcohol Drinking | 3 | 2024 | 346 | 0.260 |
Why?
|
| Internship and Residency | 2 | 2017 | 1216 | 0.260 |
Why?
|
| Epidemiologic Studies | 1 | 2007 | 40 | 0.250 |
Why?
|
| Heart Failure | 4 | 2021 | 2316 | 0.250 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8553 | 0.250 |
Why?
|
| Cross-Sectional Studies | 7 | 2018 | 3816 | 0.250 |
Why?
|
| Program Evaluation | 3 | 2021 | 441 | 0.250 |
Why?
|
| Myocardial Ischemia | 2 | 2021 | 311 | 0.240 |
Why?
|
| Healthy People Programs | 1 | 2005 | 1 | 0.240 |
Why?
|
| Demography | 1 | 2007 | 240 | 0.240 |
Why?
|
| Risk Reduction Behavior | 1 | 2007 | 149 | 0.230 |
Why?
|
| Comorbidity | 5 | 2019 | 1595 | 0.230 |
Why?
|
| Qualitative Research | 2 | 2021 | 697 | 0.230 |
Why?
|
| Artifacts | 1 | 2026 | 106 | 0.230 |
Why?
|
| Image Enhancement | 1 | 2026 | 171 | 0.220 |
Why?
|
| Age Factors | 6 | 2016 | 2844 | 0.210 |
Why?
|
| Comprehension | 2 | 2015 | 78 | 0.210 |
Why?
|
| Lactams | 1 | 2024 | 22 | 0.210 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 207 | 0.210 |
Why?
|
| Indians, North American | 2 | 2015 | 74 | 0.200 |
Why?
|
| Ritonavir | 1 | 2024 | 44 | 0.200 |
Why?
|
| Proline | 1 | 2024 | 75 | 0.200 |
Why?
|
| Echocardiography | 3 | 2026 | 1135 | 0.200 |
Why?
|
| Periodontal Attachment Loss | 1 | 2023 | 6 | 0.200 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 1410 | 0.200 |
Why?
|
| Nitriles | 1 | 2024 | 162 | 0.190 |
Why?
|
| Mexico | 1 | 2023 | 187 | 0.190 |
Why?
|
| Prostatic Neoplasms | 2 | 2009 | 1386 | 0.190 |
Why?
|
| Bone Transplantation | 1 | 2023 | 53 | 0.190 |
Why?
|
| Leucine | 1 | 2024 | 259 | 0.190 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2022 | 15 | 0.190 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2022 | 40 | 0.180 |
Why?
|
| Treatment Outcome | 6 | 2023 | 12891 | 0.180 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2021 | 65 | 0.180 |
Why?
|
| Risk Assessment | 3 | 2023 | 3712 | 0.180 |
Why?
|
| Papanicolaou Test | 1 | 2022 | 32 | 0.180 |
Why?
|
| Sex Distribution | 3 | 2013 | 317 | 0.180 |
Why?
|
| Neoplasms | 1 | 2016 | 2951 | 0.170 |
Why?
|
| Heart Diseases | 1 | 2026 | 501 | 0.170 |
Why?
|
| Maxilla | 1 | 2021 | 42 | 0.170 |
Why?
|
| Catheterization, Peripheral | 1 | 2022 | 127 | 0.170 |
Why?
|
| Geography | 2 | 2019 | 117 | 0.170 |
Why?
|
| Suicide | 1 | 2023 | 198 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 2 | 2026 | 1298 | 0.160 |
Why?
|
| West Virginia | 1 | 2020 | 7 | 0.160 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 682 | 0.160 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2022 | 272 | 0.160 |
Why?
|
| Gingivoplasty | 1 | 2020 | 4 | 0.160 |
Why?
|
| Florida | 1 | 2020 | 72 | 0.160 |
Why?
|
| Accidents, Home | 1 | 2019 | 9 | 0.160 |
Why?
|
| Simulation Training | 1 | 2022 | 168 | 0.160 |
Why?
|
| Parents | 2 | 2019 | 1108 | 0.150 |
Why?
|
| Local Government | 1 | 2019 | 3 | 0.150 |
Why?
|
| Wound Healing | 1 | 2023 | 477 | 0.150 |
Why?
|
| Maternal Age | 1 | 2019 | 134 | 0.150 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 2306 | 0.150 |
Why?
|
| Tobacco Use Disorder | 1 | 2020 | 89 | 0.150 |
Why?
|
| Cross-Over Studies | 2 | 2012 | 326 | 0.150 |
Why?
|
| Denture, Partial, Fixed | 1 | 2018 | 1 | 0.150 |
Why?
|
| Jaw, Edentulous, Partially | 1 | 2018 | 1 | 0.150 |
Why?
|
| Dental Prosthesis, Implant-Supported | 1 | 2018 | 1 | 0.150 |
Why?
|
| Influenza Vaccines | 1 | 2024 | 498 | 0.150 |
Why?
|
| Multimorbidity | 1 | 2018 | 24 | 0.140 |
Why?
|
| Poverty Areas | 1 | 2018 | 36 | 0.140 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2021 | 141 | 0.140 |
Why?
|
| Baltimore | 1 | 2018 | 43 | 0.140 |
Why?
|
| Echocardiography, Doppler | 2 | 2017 | 166 | 0.140 |
Why?
|
| Cilia | 1 | 2019 | 79 | 0.140 |
Why?
|
| Smokers | 1 | 2018 | 44 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2022 | 680 | 0.140 |
Why?
|
| Hepatitis C | 1 | 2022 | 388 | 0.140 |
Why?
|
| Prevalence | 5 | 2018 | 2683 | 0.140 |
Why?
|
| Iron | 1 | 2021 | 305 | 0.140 |
Why?
|
| Wounds, Gunshot | 1 | 2019 | 145 | 0.130 |
Why?
|
| Atrial Fibrillation | 2 | 2023 | 734 | 0.130 |
Why?
|
| Balloon Valvuloplasty | 1 | 2017 | 25 | 0.130 |
Why?
|
| Boston | 1 | 2017 | 118 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2024 | 700 | 0.130 |
Why?
|
| Brazil | 1 | 2017 | 117 | 0.130 |
Why?
|
| Dietary Supplements | 1 | 2021 | 453 | 0.130 |
Why?
|
| Health Behavior | 2 | 2013 | 389 | 0.130 |
Why?
|
| Focus Groups | 1 | 2018 | 230 | 0.130 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2016 | 10 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 285 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 4034 | 0.120 |
Why?
|
| Swine | 1 | 2020 | 1187 | 0.120 |
Why?
|
| Interviews as Topic | 3 | 2009 | 440 | 0.120 |
Why?
|
| Retrospective Studies | 5 | 2023 | 17653 | 0.120 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 219 | 0.120 |
Why?
|
| Geography, Medical | 1 | 2016 | 17 | 0.120 |
Why?
|
| Parent-Child Relations | 1 | 2018 | 253 | 0.120 |
Why?
|
| Minority Groups | 2 | 2015 | 257 | 0.120 |
Why?
|
| Professional Competence | 1 | 2016 | 96 | 0.120 |
Why?
|
| Evidence-Based Nursing | 1 | 2015 | 4 | 0.120 |
Why?
|
| Nurse Administrators | 1 | 2015 | 4 | 0.120 |
Why?
|
| Medical Staff | 1 | 2015 | 6 | 0.120 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 24 | 0.120 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 153 | 0.110 |
Why?
|
| Catheterization, Central Venous | 1 | 2017 | 142 | 0.110 |
Why?
|
| Perception | 1 | 2017 | 227 | 0.110 |
Why?
|
| Inpatients | 1 | 2020 | 546 | 0.110 |
Why?
|
| Environmental Exposure | 2 | 2014 | 290 | 0.110 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 150 | 0.110 |
Why?
|
| Environmental Health | 1 | 2014 | 20 | 0.110 |
Why?
|
| Violence | 1 | 2015 | 128 | 0.110 |
Why?
|
| Epidemiologic Methods | 1 | 2014 | 95 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 1076 | 0.110 |
Why?
|
| Disease Progression | 1 | 2021 | 2201 | 0.110 |
Why?
|
| Cadherins | 1 | 2015 | 176 | 0.110 |
Why?
|
| Linear Models | 1 | 2016 | 690 | 0.100 |
Why?
|
| Medical Informatics Applications | 1 | 2014 | 20 | 0.100 |
Why?
|
| Overweight | 1 | 2017 | 379 | 0.100 |
Why?
|
| Occupational Injuries | 1 | 2013 | 12 | 0.100 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 234 | 0.100 |
Why?
|
| Knee Injuries | 1 | 2013 | 40 | 0.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2017 | 440 | 0.100 |
Why?
|
| Automobile Driving | 1 | 2013 | 28 | 0.100 |
Why?
|
| Pregnancy | 3 | 2024 | 7492 | 0.100 |
Why?
|
| Biopsy | 1 | 2016 | 1238 | 0.100 |
Why?
|
| Chi-Square Distribution | 3 | 2010 | 567 | 0.100 |
Why?
|
| Alabama | 1 | 2012 | 44 | 0.100 |
Why?
|
| Risk-Taking | 1 | 2013 | 95 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2016 | 5085 | 0.090 |
Why?
|
| Pandemics | 1 | 2020 | 1154 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2014 | 363 | 0.090 |
Why?
|
| Health Planning | 1 | 2012 | 16 | 0.090 |
Why?
|
| Informed Consent | 1 | 2015 | 345 | 0.090 |
Why?
|
| Hearing | 1 | 2012 | 59 | 0.090 |
Why?
|
| Contact Tracing | 1 | 2012 | 57 | 0.090 |
Why?
|
| Health Services | 2 | 2003 | 69 | 0.090 |
Why?
|
| Syphilis | 1 | 2012 | 95 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2016 | 770 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2003 | 163 | 0.090 |
Why?
|
| Urban Health Services | 1 | 2011 | 15 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2011 | 117 | 0.090 |
Why?
|
| Rural Health Services | 1 | 2011 | 37 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2017 | 1684 | 0.080 |
Why?
|
| Pulmonary Surfactants | 1 | 2010 | 45 | 0.080 |
Why?
|
| Hypertension | 3 | 2016 | 1356 | 0.080 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2011 | 161 | 0.080 |
Why?
|
| Premature Birth | 1 | 2014 | 422 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2017 | 822 | 0.080 |
Why?
|
| Community Health Services | 2 | 2009 | 89 | 0.080 |
Why?
|
| Diet | 1 | 2017 | 1115 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2014 | 1221 | 0.080 |
Why?
|
| Social Class | 2 | 2010 | 205 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2015 | 87 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 171 | 0.080 |
Why?
|
| Health Promotion | 1 | 2013 | 408 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2010 | 84 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2015 | 703 | 0.070 |
Why?
|
| Manikins | 2 | 2022 | 139 | 0.070 |
Why?
|
| Logistic Models | 5 | 2014 | 1814 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 1 | 2009 | 232 | 0.070 |
Why?
|
| Incidence | 3 | 2018 | 3344 | 0.070 |
Why?
|
| Myocardial Infarction | 2 | 2013 | 998 | 0.070 |
Why?
|
| Carcinoma | 1 | 2010 | 281 | 0.070 |
Why?
|
| Cultural Characteristics | 1 | 2008 | 45 | 0.070 |
Why?
|
| Coronary Disease | 1 | 2011 | 637 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2011 | 518 | 0.060 |
Why?
|
| Office Visits | 1 | 2007 | 78 | 0.060 |
Why?
|
| Social Support | 1 | 2009 | 371 | 0.060 |
Why?
|
| Mississippi | 1 | 2006 | 35 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3114 | 0.060 |
Why?
|
| Pedigree | 3 | 2019 | 1683 | 0.060 |
Why?
|
| Insurance Claim Review | 1 | 2006 | 25 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2008 | 195 | 0.060 |
Why?
|
| Louisiana | 1 | 2006 | 137 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2006 | 270 | 0.060 |
Why?
|
| International Classification of Diseases | 1 | 2006 | 97 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2389 | 0.060 |
Why?
|
| Child Health Services | 1 | 2005 | 88 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2009 | 1232 | 0.050 |
Why?
|
| Immunization | 1 | 2005 | 265 | 0.050 |
Why?
|
| Poisson Distribution | 1 | 2004 | 50 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2004 | 59 | 0.050 |
Why?
|
| Psychotherapy, Group | 1 | 2004 | 58 | 0.050 |
Why?
|
| Urban Population | 1 | 2005 | 274 | 0.050 |
Why?
|
| Heroin | 1 | 2023 | 19 | 0.050 |
Why?
|
| Animals | 3 | 2020 | 33899 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 1841 | 0.050 |
Why?
|
| Rural Population | 1 | 2005 | 265 | 0.050 |
Why?
|
| Atrial Function, Left | 1 | 2023 | 35 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2024 | 278 | 0.050 |
Why?
|
| Wine | 1 | 2002 | 16 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2003 | 246 | 0.050 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2022 | 5 | 0.050 |
Why?
|
| Health Care Costs | 2 | 2005 | 400 | 0.050 |
Why?
|
| Infarction | 1 | 2022 | 20 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 84 | 0.050 |
Why?
|
| Physicians, Family | 1 | 2022 | 38 | 0.050 |
Why?
|
| Occupational Exposure | 1 | 2003 | 137 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2018 | 1228 | 0.040 |
Why?
|
| Family Practice | 1 | 2022 | 89 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2026 | 793 | 0.040 |
Why?
|
| Mutation | 1 | 2015 | 6139 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 54 | 0.040 |
Why?
|
| Nutrition Therapy | 1 | 2021 | 10 | 0.040 |
Why?
|
| Sarcoma | 1 | 2003 | 209 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2022 | 281 | 0.040 |
Why?
|
| Perfusion | 1 | 2022 | 212 | 0.040 |
Why?
|
| Micronutrients | 1 | 2021 | 61 | 0.040 |
Why?
|
| Survival Rate | 1 | 2006 | 2136 | 0.040 |
Why?
|
| Tricuspid Valve | 1 | 2021 | 62 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2003 | 308 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2022 | 356 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2022 | 273 | 0.040 |
Why?
|
| Heart Atria | 1 | 2022 | 335 | 0.040 |
Why?
|
| Tobacco Use | 1 | 2020 | 29 | 0.040 |
Why?
|
| Registries | 3 | 2020 | 1594 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2021 | 287 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 5221 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2024 | 482 | 0.040 |
Why?
|
| Wisconsin | 1 | 2019 | 16 | 0.040 |
Why?
|
| Heart Valves | 1 | 2019 | 52 | 0.040 |
Why?
|
| Denture Design | 1 | 2018 | 1 | 0.040 |
Why?
|
| Denture, Partial, Removable | 1 | 2018 | 1 | 0.040 |
Why?
|
| Dental Prosthesis Design | 1 | 2018 | 1 | 0.040 |
Why?
|
| Dental Restoration Failure | 1 | 2018 | 1 | 0.040 |
Why?
|
| Physicians | 1 | 2005 | 636 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6475 | 0.040 |
Why?
|
| Ischemia | 1 | 2022 | 354 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2018 | 3413 | 0.040 |
Why?
|
| Southeastern United States | 1 | 2018 | 35 | 0.040 |
Why?
|
| Pacemaker, Artificial | 1 | 2021 | 195 | 0.040 |
Why?
|
| Defibrillators, Implantable | 1 | 2021 | 215 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2019 | 191 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 230 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2017 | 1456 | 0.030 |
Why?
|
| Proteomics | 1 | 2022 | 606 | 0.030 |
Why?
|
| Dementia | 1 | 2003 | 430 | 0.030 |
Why?
|
| Pediatrics | 1 | 2007 | 1241 | 0.030 |
Why?
|
| Forecasting | 1 | 2019 | 358 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 3053 | 0.030 |
Why?
|
| Myocardium | 1 | 2022 | 864 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1479 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 1486 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 1033 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 483 | 0.030 |
Why?
|
| Food Supply | 1 | 2017 | 91 | 0.030 |
Why?
|
| California | 1 | 2016 | 127 | 0.030 |
Why?
|
| Cadherin Related Proteins | 1 | 2015 | 4 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 166 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 2745 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 451 | 0.030 |
Why?
|
| Body Patterning | 1 | 2015 | 128 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 623 | 0.030 |
Why?
|
| Public Health Administration | 1 | 2014 | 9 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 908 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 132 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2002 | 891 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 133 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 126 | 0.030 |
Why?
|
| Binomial Distribution | 1 | 2013 | 5 | 0.030 |
Why?
|
| Stroke | 1 | 2021 | 1041 | 0.020 |
Why?
|
| Zebrafish | 1 | 2015 | 419 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 427 | 0.020 |
Why?
|
| Students, Medical | 1 | 2017 | 349 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 552 | 0.020 |
Why?
|
| Global Health | 1 | 2017 | 624 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 868 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2014 | 627 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3835 | 0.020 |
Why?
|
| Vital Statistics | 1 | 2010 | 3 | 0.020 |
Why?
|
| Electronic Mail | 1 | 2010 | 41 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 716 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1387 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2556 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2014 | 852 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2010 | 255 | 0.020 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 1989 | 43 | 0.020 |
Why?
|
| Quality of Life | 1 | 2018 | 2087 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2010 | 360 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2011 | 391 | 0.020 |
Why?
|
| Hospitals | 1 | 2010 | 434 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1680 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2009 | 246 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1989 | 153 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2010 | 510 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2008 | 327 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 4479 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2005 | 139 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2008 | 527 | 0.010 |
Why?
|
| Grief | 1 | 2004 | 21 | 0.010 |
Why?
|
| Health Services Research | 1 | 2005 | 178 | 0.010 |
Why?
|
| Chromium | 1 | 2003 | 7 | 0.010 |
Why?
|
| Wood | 1 | 2003 | 8 | 0.010 |
Why?
|
| Dust | 1 | 2003 | 31 | 0.010 |
Why?
|
| Industry | 1 | 2003 | 28 | 0.010 |
Why?
|
| Self Disclosure | 1 | 2003 | 28 | 0.010 |
Why?
|
| Health Status | 1 | 2005 | 383 | 0.010 |
Why?
|
| Mental Recall | 1 | 2004 | 139 | 0.010 |
Why?
|
| Pesticides | 1 | 2003 | 34 | 0.010 |
Why?
|
| Founder Effect | 1 | 2003 | 32 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2003 | 133 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2003 | 461 | 0.010 |
Why?
|
| Haplotypes | 1 | 2003 | 522 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2005 | 383 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2003 | 597 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 4927 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 18224 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2003 | 1087 | 0.010 |
Why?
|